ANAPTYSBIO INC (ANAB) — insider trading
Health Care · NASDAQ
ANAPTYSBIO INC (ANAB) has 82 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 82 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | RENTON HOLLINGS | Director | Option exercise / conversion (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-10-01 | RENTON HOLLINGS | Director | Open-market sale | 5,000 | $49.87 | $249.4K | Form 4 |
| 2026-10-01 | RENTON HOLLINGS | Director | Option exercise / conversion | 5,000 | $18.03 | $90.2K | Form 4 |
| 2026-09-15 | Orwin John A | Director | Option exercise / conversion (derivative) | 1,300 | — | $0 | Form 4 |
| 2026-09-15 | Orwin John A | Director | Option exercise / conversion | 1,300 | — | $0 | Form 4 |
| 2026-06-15 | Orwin John A | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Orwin John A | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | RENTON HOLLINGS | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | RENTON HOLLINGS | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Schmid John P. | Director | Option exercise / conversion (derivative) | 6,030 | — | $0 | Form 4 |
| 2026-06-15 | Schmid John P. | Director | Option exercise / conversion | 6,030 | — | $0 | Form 4 |
| 2026-05-11 | Murphy Christopher M. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 25,765 | — | $0 | Form 4 |
| 2026-05-11 | Hughes Owen | Director | Grant / award / vesting (derivative) | 11,250 | — | $0 | Form 4 |
| 2026-04-27 | GRAY SUSANNAH | Director | Grant / award / vesting (derivative) | 11,250 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4/A |
| 2026-04-20 | ANAPTYSBIO, INC | 10% owner | Other acquisition or disposition | 100 | — | — | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 133,400 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 133,400 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 305,500 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 305,500 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 379,620 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 379,620 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 194,900 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 194,900 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 2,321 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 2,321 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Faga Daniel | Director, Officer (President, CEO) | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-20 | RENTON HOLLINGS | Director | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 5,500 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 9,200 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 11,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Grant / award / vesting (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-20 | Schmid John P. | Director | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Grant / award / vesting (derivative) | 8,250 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Disposition to the issuer (derivative) | 8,250 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Grant / award / vesting (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Disposition to the issuer (derivative) | 16,510 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Grant / award / vesting (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Disposition to the issuer (derivative) | 10,600 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Grant / award / vesting (derivative) | 3,311 | — | $0 | Form 4 |
| 2026-04-20 | Orwin John A | Director | Disposition to the issuer (derivative) | 3,311 | — | $0 | Form 4 |
| 2026-03-12 | Faga Daniel | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 53,334 | — | $0 | Form 4 |
| 2026-03-12 | Lizzul Paul F. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 16,667 | — | $0 | Form 4 |
Ask the chat about ANAB's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ANAPTYSBIO INC (ANAB).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.